Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. TruScreen Group Limited
  6. News
  7. Summary
    TRU   NZTRUE0001S7

TRUSCREEN GROUP LIMITED

(TRU)
  Report
End-of-day quote. End-of-day quote New Zealand Stock Exchange - 10/15
0.064 NZD   +3.23%
09/08TRUSCREEN : Annual Shareholder's Meeting Recording
PU
09/07TRUSCREEN : Shareholder Meeting Results
PU
09/06TRUSCREEN : Annual Meeting Presentation
PU
SummaryChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

TruScreen : Zimbabwe Pilot Program Underway

09/05/2021 | 10:12pm EDT

Zimbabwe's National Aids Council's TruScreen pilot program commences.

Zimbabwe's National Aids Council's (NAC) TruScreen Pilot Project is underway.

TruScreen facilitated a virtual TruScreen trainer training program in mid-August. 20 new TruScreen operators have now been trained for the pilot and 8 devices have been rolled out in the region. The initial pilot phase is to screen 500 women by October.

The pilot will compare TruScreen to visual inspection with acetic acid and cervicography (VIAC). VIAC is currently the common screening method for cervical cancer in the region. The NAC pilot hopes to have TruScreen replace VIAC as the primary cervical cancer screening tool.

Cervical cancer is the most prevalent and deadly cancer for women in Zimbabwe[1]. Women living with HIV have a six-fold increased risk of cervical cancer compared to women without HIV[2]. We hope to see continued momentum and look forward to seeing the outcome of this ground-breaking pilot programme.

References:

[1] Data source: GLOBCAN 2020, International Agency for Research on Cancer 2021
[2] Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 2020. doi:S2214-109X(20)30459-9.

Disclaimer

TruScreen Limited published this content on 06 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 September 2021 02:11:01 UTC.


ę Publicnow 2021
All news about TRUSCREEN GROUP LIMITED
09/08TRUSCREEN : Annual Shareholder's Meeting Recording
PU
09/07TRUSCREEN : Shareholder Meeting Results
PU
09/06TRUSCREEN : Annual Meeting Presentation
PU
09/05TRUSCREEN : Zimbabwe Pilot Program Underway
PU
08/31TRUSCREEN : August Stakeholders Newsletter
PU
08/27TRUSCREEN : August Stakeholders Newsletter
PU
08/04TRUSCREEN : 2021 General Meeting
PU
07/08TRUSCREEN : Director Nominations Closing Date
PU
07/01TRUSCREEN : First Sales Made in Eastern Europe
PU
06/30TRUSCREEN : to Ship Cervical Cancer Screening Devices to Serbia in July
MT
More news
Financials
Sales 2021 1,97 M 1,40 M 1,40 M
Net income 2021 -3,49 M -2,47 M -2,47 M
Net cash 2021 5,26 M 3,72 M 3,72 M
P/E ratio 2021 -9,18x
Yield 2021 -
Capitalization 23,2 M 16,4 M 16,4 M
EV / Sales 2020 6,02x
EV / Sales 2021 15,5x
Nbr of Employees -
Free-Float 70,1%
Chart TRUSCREEN GROUP LIMITED
Duration : Period :
TruScreen Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Juliet Hull Chief Executive Officer & Director
Guy Robertson Chief Financial Officer & Secretary
Peng Ho Non-Executive Chairman
Edmond Capcelea Chief Technology Officer
Nicole Melia Manager-Administration & Marketing
Sector and Competitors